Colgate-Palmolive
1,657 hedge funds and large institutions have $50.6B invested in Colgate-Palmolive in 2023 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 584 increasing their positions, 611 reducing their positions, and 130 closing their positions.
35% more call options, than puts
Call options by funds: $590M | Put options by funds: $436M
1.88% more ownership
Funds ownership: 79.1% → 80.98% (+1.9%)
3% less capital invested
Capital invested by funds: $52.1B → $50.6B (-$1.51B)
4% less repeat investments, than reductions
Existing positions increased: 584 | Existing positions reduced: 611
5% less first-time investments, than exits
New positions opened: 124 | Existing positions closed: 130
2% less funds holding
Funds holding: 1,698 → 1,657 (-41)
35% less funds holding in top 10
Funds holding in top 10: 23 → 15 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
Sarasin & Partners
London,
United Kingdom
|
+$361M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$183M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$166M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$162M |
| 5 |
JP Morgan Chase
New York
|
+$146M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$316M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$246M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$144M |
| 4 |
TCIM
TOMS Capital Investment Management
New York
|
-$123M |
| 5 |
Holocene Advisors
New York
|
-$100M |
CL Hedge Fund Activity: Q1 2023 in Review
1,657 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q1 2023, worth a combined $50.6B — down 2.9% from $52.1B a quarter earlier.
Sellers outnumbered buyers: 130 funds closed out of CL and 124 opened new positions — a net loss of 6 holders — while 611 trimmed existing stakes and 584 added.
The largest buyer was Sarasin & Partners, adding an estimated $361M. The largest seller was D.E. Shaw & Co, cutting an estimated $316M.
- 1,657 institutional investors held Colgate-Palmolive (CL) as of Q1 2023, down from 1,698 in Q4 2022.
- Funds reported $50.6B of Colgate-Palmolive stock for Q1 2023, down 2.9% quarter-over-quarter.
- 124 funds opened new Colgate-Palmolive positions in Q1 2023 and 130 closed out, a net change of -6 holders.
- The largest Colgate-Palmolive buyer in Q1 2023 was Sarasin & Partners, an estimated $361M added.
- The largest Colgate-Palmolive seller in Q1 2023 was D.E. Shaw & Co, an estimated $316M sold.
Based on aggregated 13F filings for Q1 2023.